Form 8-K - Current report:
SEC Accession No. 0001193125-21-332489
Filing Date
2021-11-17
Accepted
2021-11-17 16:16:01
Documents
12
Period of Report
2021-11-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d267305d8k.htm   iXBRL 8-K 25593
  Complete submission text file 0001193125-21-332489.txt   152120

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bvs-20211111.xsd EX-101.SCH 2893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bvs-20211111_lab.xml EX-101.LAB 18889
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bvs-20211111_pre.xml EX-101.PRE 11862
5 EXTRACTED XBRL INSTANCE DOCUMENT d267305d8k_htm.xml XML 3477
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 211420800
SIC: 3841 Surgical & Medical Instruments & Apparatus